comparemela.com

Mineralys Therapeutics Further Defines Endotype-Specific, Targeted Approach to Treatment of Uncontrolled or Resistant Hypertension with Lorundrostat Data at AHA Scientific Sessions 2023

Mineralys Therapeutics Further Defines Endotype-Specific, Targeted Approach to Treatment of Uncontrolled or Resistant Hypertension with Lorundrostat Data at AHA Scientific Sessions 2023
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Radnor ,Pennsylvania ,United States ,Philadelphia ,American ,Catalys Pacific ,Nephrol Hypertens ,Tanabe Pharma ,Tom Weible ,David Rodman ,Nasdaq ,Exchange Commission ,Globenewswire Inc ,Drug Administration ,Twitter ,Mineralys Therapeutics Inc ,Elixir Health Public Relations ,American Heart Association ,Journal Of The American Medical Association ,Heart Association ,Scientific Sessions ,Chief Medical Officer ,American Medical Association ,Aldosterone Dependent Hypertension ,Targeted Approach ,Uncontrolled Hypertension ,Mineralys Therapeutics ,States Food ,Private Securities Litigation Reform Act ,Opin Nephrol ,

comparemela.com © 2020. All Rights Reserved.